|
March 13, 2003
Institute of Medicine
The Economics of Antimalarial Drugs
London Workshop
Welcome
Kenneth Arrow, Ph.D.
Chairman
Committee on the Economics of Antimalarial Drugs
Dean Jamison, Ph.D.
Chairman
IOM Board on Global Health
Malaria In 2003 and 2013
Robert Snow, Ph.D.
Harvard University
Epidemiology of Malaria Deaths
Don deSavigny, Ph.D.
Swiss Tropical Institute
Understanding the Demand for Malaria Treatment
Patrick Kachur, M.D., MPH
Centers for Disease Control and Prevention
Influencing the Demand for Malaria Treatment
Virginia Wiseman, Ph.D.
London School of Hygiene and Tropical Medicine
Diagnostic Testing In Malaria Treatment Strategies
Patricia Graves, Ph.D., MSPH
Independent Consultant
The Role of Insecticide-treated Bednets In Malaria Control
Claire Panosian, M.D., D.T.M.H.
IOM Consultant
The Prospects for Vaccines In Malaria Control
Stephen Hoffman, M.D., D.T.M.H.
Sanaria
The Process of Changing Malaria Drug Policy: Lessons From Tanzania, Kenya and South Africa
Holly Williams, Ph.D.
Centers for Disease Control and Prevention
Evaluation of Combination Therapy At District Level In Southern Mozambique
Karen Barnes, M.D., and Charlotte Muheki, M.S.
University of Cape Town
Monitoring and Evaluating Malaria Control Programs
Jeffrey Sachs, Ph.D.
The Earth Institute
Columbia University
The Cost-effectiveness of Artemisinin Combination Therapies
Paul Coleman, Ph.D.
London School of Hygiene & Tropical Medicine
The Economics of Malaria Resistance and The Optimal Use of Artemisinin Combination Therapies
Ramanan Laxminarayan, Ph.D., MPH
Resources for the Future
Financing Malaria Control By the World Bank and International Finance Corporation
Ed Elmendorf, MPH
World Bank
The Pharmaceutical Industry, Pharmaceutical Technology and Regulation In Improving Antimalarial Drugs
John Horton, M.D.
Independent Consultant
|